Our results suggested that higher EMMPRIN expression was obviously associated with worse clinicopathological features, including tumor stage (T3+T4/T1+T2), except for cervical cancer (HR=1.35, 95%CI:0.73-2.48, p=0.33), poor/ well+ moderate differentiation rate, clinical stage (III+IV / I +II) and nodal metastasis (negative/positive). The gene discussed is BSG; the disease is neoplasm.